Literature DB >> 22938181

An infant with human parechovirus type 3 infection with a distinctive rash on the extremities.

Kensuke Shoji1, Hisako Komuro, Yoshinori Kobayashi, Tatsuhiko Shike, Takanori Funaki, Tomohiro Katsuta, Ippei Miyata, Akihiko Saitoh.   

Abstract

Human parechovirus type 3 (HPeV3) is known to cause sepsis-like syndrome and meningoencephalitis in neonates and young infants. We herein report a neonatal case of sepsis-like syndrome due to HPeV3 infection, diagnosed using polymerase chain reaction (PCR), with a distinctive erythematous rash present mainly on the soles and palms that helped in the diagnosis of the disease. Combining the unique characteristics of rash and confirmation by PCR at the early stage of the disease led to the diagnosis of HPeV3, distinguishing it from sepsis and other critical disease conditions, and allowing for appropriate, rapid management.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22938181     DOI: 10.1111/j.1525-1470.2012.01819.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  Intracranial hemorrhage and other symptoms in infants associated with human parechovirus in Vienna, Austria.

Authors:  Herbert Kurz; Ruth Prammer; Wolfgang Bock; Robert Ollerieth; Günther Bernert; Karl Zwiauer; Judith H Aberle; Stephan W Aberle; Tamas Fazekas; Wolfgang Holter
Journal:  Eur J Pediatr       Date:  2015-06-25       Impact factor: 3.860

2.  Distinctive clinical features of HPeV-3 infection in 2 neonates with a sepsis-like illness.

Authors:  Jung Sook Yeom; Ji Sook Park; Ji-Hyun Seo; Eun Sil Park; Jae-Young Lim; Chan-Hoo Park; Hyang-Ok Woo; Hee-Shang Youn; Ok Jeong Lee; Tae-Hee Han; Ju-Young Chung
Journal:  Korean J Pediatr       Date:  2016-07-31

3.  Clinical features and seasonality of parechovirus infection in an Asian subtropical city, Hong Kong.

Authors:  Grace P K Chiang; Zigui Chen; Martin C W Chan; Simon H M Lee; Angela K Kwok; Apple C M Yeung; E Anthony S Nelson; Kam Lun Hon; Ting Fan Leung; Paul K S Chan
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.